4//SEC Filing
Holbrook Kerr 4
Accession 0001606498-24-000040
CIK 0001606498other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:04 PM ET
Size
7.0 KB
Accession
0001606498-24-000040
Insider Transaction Report
Form 4
Holbrook Kerr
SVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2024-03-06$19.14/sh+36,573$700,007→ 89,814 total - Tax Payment
Common Stock
2024-03-06$19.00/sh−2,618$49,742→ 87,196 total
Footnotes (3)
- [F1]Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 6, 2025, 1/3 on March 6, 2026 and 1/3 on March 6, 2027.
- [F2]Total beneficially owned includes 149 shares acquired on December 31, 2023 and 782 shares acquired on June 30, 2023 under the Issuer's Employee Stock Purchase Plan.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of TRSUs awarded to the Reporting Person on March 6, 2023, of which 1/3 vested on March 6, 2024, 1/3 will vest on March 6, 2025 and the remaining 1/3 will vest on March 6, 2026.
Documents
Issuer
AVANOS MEDICAL, INC.
CIK 0001606498
Entity typeother
Related Parties
1- filerCIK 0001861246
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:04 PM ET
- Size
- 7.0 KB